Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/beta-catenin signaling
ONCOLOGY REPORTS
Authors: Sun, Qi; Fu, Qiuxia; Li, Shiyue; Li, Junjun; Liu, Shanshan; Wang, Zhongyuan; Su, Zijie; Song, Jiaxing; Lu, Desheng
Abstract
Emetine, an amoebicidal drug, exerts potent anticancer activity against various solid tumors, however, the underlying molecular mechanism remains unclear. In the present study, the effects of emetine were investigated on various proteins involved in the Wnt/beta-catenin signaling pathway, which has been linked to various human cancers. It was revealed that emetine blocked Wnt/beta-catenin signaling by targeting components of this pathway, including the low-density lipoprotein-receptor-related protein 6 (LRP6) and disheveled (DVL). Moreover, nanomolar concentrations of emetine decreased phosphorylation of these proteins and suppressed the expression of Wnt target genes, including fibronectin, frizzled-7 (Fzd7), c-Myc, Nanog and CD133 in MDA-MB-231 and MDA-MB-468 breast cancer cells. Additionally, emetine treatment induced apoptosis and suppressed the viability, migration, invasion, and sphere formation of breast cancer cells. Collectively the present results indicated that emetine antagonizes Wnt/beta-catenin signaling, providing insight into the molecular mechanism underlying the anticancer activity of emetine.
Structure of human Frizzled5 by fiducial-assisted cryo-EM supports a heterodimeric mechanism of canonical Wnt signaling
ELIFE
Authors: Tsutsumi, Naotaka; Mukherjee, Somnath; Waghray, Deepa; Janda, Claudia Y.; Jude, Kevin M.; Miao, Yi; Burg, John S.; Aduri, Nanda Gowtham; Kossiakoff, Anthony A.; Gati, Cornelius; Garcia, K. Christopher
Abstract
Frizzleds (Fzd) are the primary receptors for Wnt morphogens, which are essential regulators of stem cell biology, yet the structural basis of Wnt signaling through Fzd remains poorly understood. Here we report the structure of an unliganded human Fzd5 determined by single-particle cryo-EM at 3.7 angstrom resolution, with the aid of an antibody chaperone acting as a fiducial marker. We also analyzed the topology of low-resolution XWnt8/Fzd5 complex particles, which revealed extreme flexibility between the Wnt/Fzd-CRD and the Fzd-TM regions. Analysis of Wnt/beta-catenin signaling in response to Wnt3a versus a 'surrogate agonist' that cross-links Fzd to LRP6, revealed identical structure-activity relationships. Thus, canonical Wnt/beta-catenin signaling appears to be principally reliant on ligand-induced Fzd/LRP6 heterodimerization, versus the allosteric mechanisms seen in structurally analogous class A G protein-coupled receptors, and Smoothened. These findings deepen our mechanistic understanding of Wnt signal transduction, and have implications for harnessing Wnt agonism in regenerative medicine.